![Health Conversation artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts124/v4/28/fb/17/28fb171a-e14a-4d1b-a9cd-d18188cd6187/mza_10725344026324069.jpeg/100x100bb.jpg)
What would be the impact of a TRIPS waiver extension?
Health Conversation
English - November 21, 2022 14:44 - 16 minutes - 38.2 MB - ★★★★★ - 1 ratingMedicine Health & Fitness Alternative Health health covid-19 r&d patients vaccines pharmaceutical pharma pharmaceutical industry research & development patient safety Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: How can we support medical innovation in Europe?
Welcome to Health Conversation. Today we're asking Peter Guenter, CEO of Healthcare at Merck, 'What would be the impact of a TRIPS waiver extension?'. Listen to hear their discussion on the challenge and how we're preparing for the future.
Hosted on Acast. See acast.com/privacy for more information.